| Tag | Content |
|---|
EnhancerAtlas ID | HS023-15395 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr2:216544950-216547370 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gata1 | MA0035.3 | chr2:216546475-216546486 | AGAGATAAGGA | - | 6.02 | | IRF1 | MA0050.2 | chr2:216545601-216545622 | GAGAGAAAAGTGAAACAAATA | - | 6.13 | | MITF | MA0620.2 | chr2:216546738-216546756 | GAGGGTCACATGACTTCA | + | 6.13 | | MITF | MA0620.2 | chr2:216546738-216546756 | GAGGGTCACATGACTTCA | - | 6.13 | | Stat6 | MA0520.1 | chr2:216546819-216546834 | CATTTCTTGAGAACT | + | 7.19 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_02680 | chr2:216545306-216547009 | Astrocytes | | SE_45570 | chr2:216544833-216547498 | Osteoblasts | | SE_55663 | chr2:216543789-216547470 | u87 | | SE_67699 | chr2:216543789-216547470 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I215680 | chr2 | 216545057 | 216547522 |
|
Enhancer Sequence | GCTATAAATA TTCAGAAAAA TTTTAGAAGT TGATGTTCCT CGATGAGAAC ACATGGACAC 60
CTGGGAGGGG AACAACACAC ACTGGGGTCT GACGGCGGGG GCGGGGGAGG GAGAGCATCA 120
GGAAGAACAG CTAAGGGATG CTGGGCTTAA TACCTAGGGG ATGAGTTGAT CTGTGCAGCA 180
AACCACCATG CCCCACGTTT ACCTACGTAA CAAACCTGCA CATCCCTCAC ATGTATCTCG 240
GAACTTAAAA TGAAAATTGA TTAAAAAAAA AGAATAAAAG TAGAGATGAA AGAAATGGAT 300
GTTCCTAAAA GAAACAACAG ATACCTTTTA AAATACACTT TCAGTATAAC TAAGTACCTT 360
TTCAAGTTGG TTAAAAAATT CTAAAAGTAG AGTAGTCAAG TCCTTAAGTA ACATGACGAT 420
CCTATCTACA GTTTAAATAA ATGTTCAGTC ATCCCAACAG GAACAAATCA TAAAGAAAAT 480
GTAAAGAATA TATCAAATTG GCTAAATGCA TTCTATATTC GTAGTGTACT CACTGAAGCA 540
TTGTTCGTGG GTTTTTTTTT TCTGATTCTT ACCAAGCCTA CATATTTCTT TTTAATTTTT 600
TCTTTTTATG TTTCCCAAGT TTACAGTTCA CATAAAATAC CCACTGAAGC AGAGAGAAAA 660
GTGAAACAAA TATTTCACAG CTCTTTGGGG ATTTGAATGG GTTTTTACAA TAAAACCTTG 720
ATTACTCAAA GAGCACAGGA GTGCCTGAAA CCTGATAGAA GGAACAGAGA GCAGGCAGTT 780
CTAAAGGTGC CAAGAGAGAC TCAGAACCTT GTGGAGTTGA TGCACTGGCC CTTCAACCCT 840
GGAACCCAGG CCAAGCACCA AACCAGGAAG GGTCCAAACA GCCCTGAACA TGGCTATCGT 900
GGCCAAACAA ACCAAAAAAA AAAAAGTCAC TTGGAAAAGA TGTGCAAGGT TGTGGTTTCC 960
TGATAAATTA AGATGACACA GGCAGTACCA CAGGGCTTCC TTCATTACAT TATTGTGAAA 1020
TCTGGACTCA AATAGAATGA GGCAAACCCA CAAGTTAAAG TGTTTTTAAA GTGGCTCAAT 1080
AATCACTTTG AAAACAGAAC ACCCTTTCAG TCAGCATGAC TGGAACTTTG ATCAACAAAT 1140
CCCCAAGAGC CACAACCCGT CTTTTGTGAA CAAGTAGTAT CAAGGTGGGG GTGGGCTTGG 1200
AGTGCACTGG ATGCTTTTCT TCTTTCATCA TGAAACCTGG TGGTTTTGTG TCATGTGATA 1260
TGTTTTTCAG AGATTCGGCA GGAAGCTTGC ACCGAGTGAA GGATTTATAA AGATTATAGG 1320
AGATAACACA AAGCTATTTT ATCTCTTTAA AAAAAATCAA AGGTATTAAA TTTTTTTCTA 1380
CTTCATTTTT GTTTCCTCAT TTAAAAATTA GCTGCCACAA ATATTATCCC CCATCTGGGC 1440
ACAAGGTCAG TTGGCATACA ATTTTCTTCT TAATTTTCAT TTTCTGGATT CCTTGATGAC 1500
CTGATTTTGT ACAAATTCAT GCTGCAGAGA TAAGGATTGA TTGGCTACAA ATCAAGGATC 1560
TCTGCAGAAT GGGAATGAGA GACAAAGGAA GAGGAAGAGG ACGGACACCA CAAACCATCT 1620
TATCTTTTCA AAATGTGATT GGTGCATTTT CAACATTGGC TTACCTTTCC TTATGCTGTC 1680
CATAAATTTT GTGCAGGTGT AAGCTCATCC TACACATGTC ATTTGGACCA GACCAAGGCT 1740
GCTGTCATGG AGGACCCACA CCACAGCTTG GGAACCATTC ATCTACCAGA GGGTCACATG 1800
ACTTCAAATG ACTCTTCTAG GGGCCACCTG CCATGATAGG GTACCAGCTC TTCCTCTGAA 1860
TTCCCAATCC ATTTCTTGAG AACTACTGTT TCTAATAAGG TACTGTTTCT AATACCTTTC 1920
CAACAATGGT TTATTCATTT ATCCATACAT TTAAAATACA GATTTTTTTT AGCATCTGCC 1980
ATGTTTAAGA TCCTCCTCTA GCACTAGGAA TACATTATTG AATAGAACAA AGTCCCTGAT 2040
TTCATGGTGT TTACATTTCA AGGGAGAACT ATTCCTTCTT AGAACAGAAC ACCGTACAAA 2100
GTTGTAACAT AGTAAGTGAA AGTGCTCTGG CCAAGGCTGA GACCACAGTC TACCACGAGC 2160
TCCTTGCATT GTGAAGAATG AATATTTCTT AAGCACTTAA CTGTGTGCCA GGCATTGTGT 2220
AAAGTCCTAA TATACATTTG CTTCCTCATC GGGTGGGAAG TTGAGCAGGA GGCTTTCTAA 2280
AGTGTCTATT AAAACCCAAG TTATTTGGTT GGCCACTTTA GTCTGTGGTG GATTATCTGC 2340
ACATTTTTGC CTAGAGATCA CTTAATCTGT GGCATAGAAA AACTATATTC AATTGGCCGT 2400
GTGTAGTGGC TTAACGCCTG 2420
|
